Helmut Prosch
Helmut Prosch
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
The EFSUMB guidelines and recommendations for the clinical practice of contrast-enhanced ultrasound (CEUS) in non-hepatic applications: update 2017 (long version)
PS Sidhu, V Cantisani, CF Dietrich, OH Gilja, A Saftoiu, E Bartels, ...
Ultraschall in der Medizin-European journal of ultrasound 39 (02), e2-e44, 2018
European position statement on lung cancer screening
M Oudkerk, A Devaraj, R Vliegenthart, T Henzler, H Prosch, CP Heussel, ...
The Lancet Oncology 18 (12), e754-e766, 2017
Risk factors for diabetes insipidus in langerhans cell histiocytosis
N Grois, U Pötschger, H Prosch, M Minkov, M Arico, J Braier, JI Henter, ...
Pediatric blood & cancer 46 (2), 228-233, 2006
COVID-19 patients and the Radiology department–advice from the European Society of Radiology (ESR) and the European Society of Thoracic Imaging (ESTI)
MP Revel, AP Parkar, H Prosch, M Silva, N Sverzellati, F Gleeson, ...
European radiology 30 (9), 4903-4909, 2020
Cardiopulmonary recovery after COVID-19: an observational prospective multicentre trial
T Sonnweber, S Sahanic, A Pizzini, A Luger, C Schwabl, B Sonnweber, ...
European Respiratory Journal 57 (4), 2021
MR imaging presentation of intracranial disease associated with Langerhans cell histiocytosis
D Prayer, N Grois, H Prosch, H Gadner, AJ Barkovich
American journal of neuroradiology 25 (5), 880-891, 2004
Central nervous system disease in Langerhans cell histiocytosis
N Grois, B Fahrner, RJ Arceci, JI Henter, K McClain, H Lassmann, ...
The Journal of pediatrics 156 (6), 873-881. e1, 2010
Neuropathology of CNS disease in Langerhans cell histiocytosis
N Grois, D Prayer, H Prosch, H Lassmann
Brain 128 (4), 829-838, 2005
Langerhans cell histiocytosis in neonates
M Minkov, H Prosch, M Steiner, N Grois, U Pötschger, P Kaatsch, ...
Pediatric blood & cancer 45 (6), 802-807, 2005
Automatic lung segmentation in routine imaging is primarily a data diversity problem, not a methodology problem
J Hofmanninger, F Prayer, J Pan, S Röhrich, H Prosch, G Langs
European Radiology Experimental 4 (1), 1-13, 2020
Intraoperative extracorporeal membrane oxygenation and the possibility of postoperative prolongation improve survival in bilateral lung transplantation
K Hoetzenecker, S Schwarz, M Muckenhuber, A Benazzo, F Frommlet, ...
The Journal of thoracic and cardiovascular surgery 155 (5), 2193-2206. e3, 2018
Successful treatment of disseminated Acanthamoeba sp. infection with miltefosine
AC Aichelburg, J Walochnik, O Assadian, H Prosch, A Steuer, ...
Emerging infectious diseases 14 (11), 1743, 2008
Central diabetes insipidus as presenting symptom of Langerhans cell histiocytosis
H Prosch, N Grois, D Prayer, F Waldhauser, M Steiner, M Minkov, ...
Pediatric blood & cancer 43 (5), 594-599, 2004
Evaluation of diffusion-weighted MRI for pretherapeutic assessment and staging of lymphoma: results of a prospective study in 140 patients
ME Mayerhoefer, G Karanikas, K Kletter, H Prosch, B Kiesewetter, ...
Clinical Cancer Research 20 (11), 2984-2993, 2014
Review of cancer treatment with immune checkpoint inhibitors
C Thallinger, T Füreder, M Preusser, G Heller, L Müllauer, C Höller, ...
Wiener Klinische Wochenschrift 130 (3), 85-91, 2018
Course and clinical impact of magnetic resonance imaging findings in diabetes insipidus associated with Langerhans cell histiocytosis
N Grois, D Prayer, H Prosch, M Minkov, U Pötschger, H Gadner
Pediatric blood & cancer 43 (1), 59-65, 2004
ESR/ERS statement paper on lung cancer screening
HU Kauczor, AM Baird, TG Blum, L Bonomo, C Bostantzoglou, ...
European Radiology 30 (6), 3277-3294, 2020
Pattern and course of neurodegeneration in Langerhans cell histiocytosis
M Wnorowski, H Prosch, D Prayer, G Janssen, H Gadner, N Grois
The Journal of pediatrics 153 (1), 127-132, 2008
Lung transplantation for COVID-19-associated acute respiratory distress syndrome in a PCR-positive patient
C Lang, P Jaksch, MA Hoda, G Lang, T Staudinger, E Tschernko, ...
The Lancet Respiratory Medicine 8 (10), 1057-1060, 2020
Liquid-biopsy-based identification of EGFR T790M mutation-mediated resistance to afatinib treatment in patients with advanced EGFR mutation-positive NSCLC, and subsequent …
MJ Hochmair, A Buder, S Schwab, OC Burghuber, H Prosch, W Hilbe, ...
Targeted oncology 14 (1), 75-83, 2019
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20